Principals of the firm Aplos Medical - formerly doing business as CT Resources) have developed Omega PF, a game-changing, next era GERD treatment that it is suggested surgeons can easily replicate. The system controls reflux without agony to the patient. It is MRI compatible, no dysphagia, simple laparoscopic implantation without altering anatomy. Currently in clinical trial supported by NIH SBIR grant. The first patient was implanted in August 2023 with a very happy patient having all his GERD symptoms gone. Patents granted in the US, Europe, and China. The device is the ideal solution for the millions of GERD patients failing their PPI medication management. It is a turning point in GERD treatments, and a $billion business opportunity.
